Table 1 Clinical characteristics of the 115 people living with HIV with acute intoxication associated to chemsex
Characteristics | Total | Severe acute intoxication | Non-severe acute intoxication | p |
|---|---|---|---|---|
n | 115 | 12 (10.4%) | 103 (89.6%) | |
Age 1 | 35.6±7 | 35.3±8 | 35.4±7 | 0.94 |
MSM | 111 (96.5%) | 12 (100%) | 99 (89.5%) | 0.64 |
Bisexual men | 4 (3.5%) | 0 (0.0%) | 4 (10.5%) | |
Spanish citizen | 107 (93.0%) | 11 (91.7%) | 96 (93.2%) | 0.84 |
Stable housing | 115 (100%) | 12 (100%) | 103 (100%) | 1 |
Mental health disorder | 32 (27.8%) | 7 (58.3%) | 25 (24.3%) | 0.02 |
IgG antibodies hepatitis C | 13 (11.3%) | 1 (9.1%) | 12 (13.1%) | 0.89 |
CD4 lymphocyte | ||||
total 2 | 624 (500–765) | 518 (395–639) | 630 (512–800) | 0.04 |
≥500 cells/mm3 | 89 (77.3%) | 6 (50%) | 83 (80.6%) | 0.03 |
VIH-1 RNA < 50 copies/mL | 99 (86.1%) | 9 (75.0%) | 90 (87.4%) | 0.22 |
IGI | 78 (67.8%) | 9 (75%) | 69 (67.0%) | |
NNRTI | 22 (19.1%) | 1 (8.3%) | 21 (20.4%) | 0.53 |
PI | 15 (13.0%) | 2 (16.7%) | 13 (12.6%) | |
Inhibitor drug-drug interactions | 36 (31.3%) | 4 (33.3%) | 32 (31.1%) | 0.55 |
Poly-drug use | 51 (44.3%) | 5 (41.6%) | 46 (44.6%) | 0.84 |